K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients
- PMID: 9740272
K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients
Abstract
Paraffin embedded tissues from twenty Thai patients with intrahepatic cholangiocarcinomas were studied for K-ras gene mutations at codon 12, 13 and 61 and for p53 gene mutations in exon 5 to 8 using polymerase chain reaction and thermal cycle sequencing. Results showed that point mutations at these regions in K-ras oncogene were not present in all the samples. One case harbored a p53 gene mutation in codon 282 in exon 8, CGG (arginine) to TGG (tryptophan), but the mutation was not found in other patient's tissues with similar histological features.
Similar articles
-
The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.J Med Assoc Thai. 1998 May;81(5):316-23. J Med Assoc Thai. 1998. PMID: 9623030 Clinical Trial.
-
Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.Lab Invest. 1999 Apr;79(4):477-83. Lab Invest. 1999. PMID: 10212000
-
Cancer genes and cholangiocarcinoma.Southeast Asian J Trop Med Public Health. 1997;28 Suppl 1:80-4. Southeast Asian J Trop Med Public Health. 1997. PMID: 9656355
-
p53 Mutations in human cholangiocarcinoma: a review.Liver Int. 2005 Aug;25(4):704-16. doi: 10.1111/j.1478-3231.2005.01106.x. Liver Int. 2005. PMID: 15998419 Review.
-
Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component.Mod Pathol. 2001 May;14(5):527-32. doi: 10.1038/modpathol.3880342. Mod Pathol. 2001. PMID: 11353065 Review.
Cited by
-
Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.World J Gastroenterol. 2007 Jun 7;13(21):2986-91. doi: 10.3748/wjg.v13.i21.2986. World J Gastroenterol. 2007. PMID: 17589952 Free PMC article.
-
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Cell Biosci. 2011 Jan 24;1(1):5. doi: 10.1186/2045-3701-1-5. Cell Biosci. 2011. PMID: 21711594 Free PMC article.
-
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb. PLoS Genet. 2014. PMID: 24550739 Free PMC article.
-
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).World J Gastroenterol. 2005 Jun 14;11(22):3392-7. doi: 10.3748/wjg.v11.i22.3392. World J Gastroenterol. 2005. PMID: 15948244 Free PMC article.
-
In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma.Cancer Res. 2022 Apr 15;82(8):1548-1559. doi: 10.1158/0008-5472.CAN-21-2556. Cancer Res. 2022. PMID: 35074757 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous